Browse

Effective removal of leptin via hemodiafiltration with on-line endogenous reinfusion therapy

DC Field Value Language
dc.contributor.authorKim, S.-
dc.contributor.authorOh, K. H.-
dc.contributor.authorChin, H. J.-
dc.contributor.authorNa, K. Y.-
dc.contributor.authorChae, D. -W.-
dc.contributor.authorHan, J. S.-
dc.contributor.authorJoo, K. W.-
dc.contributor.authorKim, S.-
dc.contributor.authorAhn, C.-
dc.contributor.authorKim, Y. S.-
dc.date.accessioned2012-06-26T05:08:36Z-
dc.date.available2012-06-26T05:08:36Z-
dc.date.issued2009-12-
dc.identifier.citationCLINICAL NEPHROLOGY; Vol.72 6; 442-448ko_KR
dc.identifier.issn0301-0430-
dc.identifier.urihttps://hdl.handle.net/10371/77427-
dc.description.abstractAims: Leptin is a middle-molecular weight uremic toxin. Hemodiafiltration with on-line endogenous reinfusion (HFR) is a novel dialytic method combining the processes of diffusion, convection and adsorption. We performed a prospective crossover study of patients with end-stage renal disease to investigate the effect of HFR therapy on the level of leptin as compared to conventional low flux hemodialysis (LHD). Methods: Eleven stable hemodialysis patients were treated with LHD for 12 weeks and then treated with HFR (SG30 Plus; Sorin Group Italia S.r.1, Mirandola, Italy) for 12 weeks. Results: After 12 weeks of HFR treatment, serum leptin levels significantly decreased (17.1 (2.66 - 39.5) at Week 12 vs. 12.3 (1.80 - 24.3) ng/ml at Week 24, p = 0.014). Although serum adiponectin levels also decreased (1.66 (1.44 - 1.86) at Week 12 vs. 1.12 (0.79 - 1.34) g/ml at Week 24, p = 0.001), the ratio of leptin to adiponectin did not increase after HFR treatment. Serum beta 2-microglobulin (beta(2)M) levels significantly decreased (37.7 (29.8 - 42.6) at Week 12 vs. 28.3 (26.5 - 32.2) mg/dl at Week 24, p = 0.002). Dry weight, Kt/V(urea), normalized protein equivalent of nitrogen appearance, subjective global assessment, and serum albumin levels of the patients were not changed after HFR treatment. There was no difference in the serum levels of C-reactive protein or interleukin-6 between Week 12 and Week 24. Conclusions: The results of our study indicate that HFR may be a better therapy than LHD for removal of middle-molecular-weight uremic toxins such as leptin and beta(2)M.ko_KR
dc.language.isoenko_KR
dc.publisherDUSTRI-VERLAG DR KARL FEISTLEko_KR
dc.subjectleptinko_KR
dc.subjecthemodialysisko_KR
dc.subjectend-stage kidney diseaseko_KR
dc.subjecthemodiafiltrationko_KR
dc.subjectbeta 2-microglobulinko_KR
dc.titleEffective removal of leptin via hemodiafiltration with on-line endogenous reinfusion therapyko_KR
dc.typeArticleko_KR
dc.citation.journaltitleCLINICAL NEPHROLOGY-
dc.description.citedreferenceWratten ML, 2007, CONTRIB NEPHROL, V158, P94-
dc.description.citedreferenceBeltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003-
dc.description.citedreferenceBolasco PG, 2006, INT J ARTIF ORGANS, V29, P1042-
dc.description.citedreferencePanichi V, 2006, NEPHROL DIAL TRANSPL, V21, P756, DOI 10.1093/ndt/gfi189-
dc.description.citedreferenceBossola M, 2005, ARTIF ORGANS, V29, P259, DOI 10.1111/j.1525-1594.2005.29047.x-
dc.description.citedreferenceMeloni C, 2005, CLIN NEPHROL, V63, P106-
dc.description.citedreferenceZoccali C, 2005, J RENAL NUTR, V15, P125, DOI 10.1053/j.jrn.2004.09.036-
dc.description.citedreferenceSatoh N, 2004, DIABETES CARE, V27, P2488-
dc.description.citedreferenceHuang JW, 2004, AM J KIDNEY DIS, V43, P1047, DOI 10.1053/j.ajkd.2004.02.017-
dc.description.citedreferencePajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200-
dc.description.citedreferenceCorreia MLD, 2004, CURR OPIN NEPHROL HY, V13, P215, DOI 10.1097/01.mnh.0000119533.79618.b3-
dc.description.citedreferenceWerner N, 2004, ARTERIOSCL THROM VAS, V24, P7, DOI 10.1161/01.ATV.0000110908.43721.ad-
dc.description.citedreferenceBossola M, 2004, NEPHRON CLIN PRACT, V97, P76, DOI 10.1159/000078634-
dc.description.citedreferenceWinchester JF, 2004, BLOOD PURIFICAT, V22, P73, DOI 10.1159/000074926-
dc.description.citedreferenceRAGAZZONI E, 2004, G ITAL NEFROL S30, V21, pS85-
dc.description.citedreferenceMeloni C, 2004, BLOOD PURIFICAT, V22, P505, DOI 10.1159/000082040-
dc.description.citedreferenceClark WR, 2003, ADV RENAL REPLACE TH, V10, P270, DOI 10.1053/j.arrt.2003.11.004-
dc.description.citedreferenceLandt M, 2003, CLIN ENDOCRINOL, V59, P44-
dc.description.citedreferenceEsposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799-
dc.description.citedreferencePajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200-
dc.description.citedreferenceSoderberg S, 2003, CEREBROVASC DIS, V15, P63, DOI 10.1159/000067128-
dc.description.citedreferenceChristensson L, 2002, EUR J CLIN NUTR, V56, P810, DOI 10.1038/sj.ejcn.1601394-
dc.description.citedreferenceZoccali C, 2002, J AM SOC NEPHROL, V13, P134-
dc.description.citedreferenceHORL WH, 2002, J AM SOC NEPHROL S1, V13, P62-
dc.description.citedreferenceWard RA, 2000, J AM SOC NEPHROL, V11, P2344-
dc.description.citedreferenceMenendez C, 2000, EUR J ENDOCRINOL, V143, P711, DOI 10.1530/eje.0.1430711-
dc.description.citedreferencede Francisco ALM, 2000, BLOOD PURIFICAT, V18, P231-
dc.description.citedreferenceSoderberg S, 1999, J INTERN MED, V246, P409-
dc.description.citedreferenceStenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x-
dc.description.citedreferenceArita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255-
dc.description.citedreferenceZimmermann J, 1999, KIDNEY INT, V55, P648-
dc.description.citedreferenceLevey AS, 1998, AM J KIDNEY DIS, V32, P853-
dc.description.citedreferenceNordfors L, 1998, KIDNEY INT, V54, P1267-
dc.description.citedreferenceMerabet E, 1997, J CLIN ENDOCR METAB, V82, P847-
dc.description.citedreferenceGHEZZI PM, 1992, ASAIO J, V38, P61-
dc.description.citedreferenceGOTCH FA, 1985, KIDNEY INT, V28, P526-
dc.description.tc5-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse